151 related articles for article (PubMed ID: 17629699)
1. Synthesis and optimization of novel and selective muscarinic M(3) receptor antagonists.
Kumar N; Kaur K; Aeron S; Dharmarajan S; Silamkoti AD; Mehta A; Gupta S; Chugh A; Gupta JB; Salman M; Palle VP; Cliffe IA
Bioorg Med Chem Lett; 2007 Sep; 17(18):5256-60. PubMed ID: 17629699
[TBL] [Abstract][Full Text] [Related]
2. 1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.
Sonda S; Katayama K; Fujio M; Sakashita H; Inaba K; Asano K; Akira T
Bioorg Med Chem Lett; 2007 Feb; 17(4):925-31. PubMed ID: 17188867
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists.
Naito R; Yonetoku Y; Okamoto Y; Toyoshima A; Ikeda K; Takeuchi M
J Med Chem; 2005 Oct; 48(21):6597-606. PubMed ID: 16220976
[TBL] [Abstract][Full Text] [Related]
4. First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.
Provins L; Christophe B; Danhaive P; Dulieu J; Durieu V; Gillard M; Lebon F; Lengelé S; Quéré L; van Keulen B
Bioorg Med Chem Lett; 2006 Apr; 16(7):1834-9. PubMed ID: 16439121
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.
Böhme TM; Keim C; Kreutzmann K; Linder M; Dingermann T; Dannhardt G; Mutschler E; Lambrecht G
J Med Chem; 2003 Feb; 46(5):856-67. PubMed ID: 12593665
[TBL] [Abstract][Full Text] [Related]
6. Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.
Dallanoce C; De Amici M; Barocelli E; Bertoni S; Roth BL; Ernsberger P; De Micheli C
Bioorg Med Chem; 2007 Dec; 15(24):7626-37. PubMed ID: 17889543
[TBL] [Abstract][Full Text] [Related]
7. Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD.
Starck JP; Provins L; Christophe B; Gillard M; Jadot S; Lo Brutto P; Quéré L; Talaga P; Guyaux M
Bioorg Med Chem Lett; 2008 Apr; 18(8):2675-8. PubMed ID: 18359633
[TBL] [Abstract][Full Text] [Related]
8. The effect of absolute configuration on activity, subtype selectivity (M3/M2) of 3α-acyloxy-6β-acetoxyltropane derivatives as muscarinic M3 receptor antagonists.
Wang ZP; Liu HZ; Zhu L; Hu YM; Cui YY; Niu YY; Lu Y; Chen HZ
Bioorg Med Chem; 2013 Mar; 21(5):1234-9. PubMed ID: 23375092
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.
Sagara Y; Sagara T; Uchiyama M; Otsuki S; Kimura T; Fujikawa T; Noguchi K; Ohtake N
J Med Chem; 2006 Sep; 49(19):5653-63. PubMed ID: 16970392
[TBL] [Abstract][Full Text] [Related]
10. The discovery of AZD9164, a novel muscarinic M3 antagonist.
Mete A; Bowers K; Chevalier E; Donald DK; Edwards H; Escott KJ; Ford R; Grime K; Millichip I; Teobald B; Russell V
Bioorg Med Chem Lett; 2011 Dec; 21(24):7440-6. PubMed ID: 22047691
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.
Scapecchi S; Nesi M; Matucci R; Bellucci C; Buccioni M; Dei S; Guandalini L; Manetti D; Martelli C; Martini E; Marucci G; Orlandi F; Romanelli MN; Teodori E; Cirilli R
J Med Chem; 2010 Jan; 53(1):201-7. PubMed ID: 19928767
[TBL] [Abstract][Full Text] [Related]
12. Lead generation using pharmacophore mapping and three-dimensional database searching: application to muscarinic M(3) receptor antagonists.
Marriott DP; Dougall IG; Meghani P; Liu YJ; Flower DR
J Med Chem; 1999 Aug; 42(17):3210-6. PubMed ID: 10464008
[TBL] [Abstract][Full Text] [Related]
13. Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.
Starck JP; Talaga P; Quéré L; Collart P; Christophe B; Lo Brutto P; Jadot S; Chimmanamada D; Zanda M; Wagner A; Mioskowski C; Massingham R; Guyaux M
Bioorg Med Chem Lett; 2006 Jan; 16(2):373-7. PubMed ID: 16275087
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of m1 selective muscarinic receptor antagonists1.
Augelli-Szafran CE; Blankley CJ; Jaen JC; Moreland DW; Nelson CB; Penvose-Yi JR; Schwarz RD; Thomas AJ
J Med Chem; 1999 Feb; 42(3):356-63. PubMed ID: 9986705
[TBL] [Abstract][Full Text] [Related]
15. Quantitative structure-selectivity relationship for M2 selectivity between M1 and M2 of piperidinyl piperidine derivatives as muscarinic antagonists.
Niu YY; Yang LM; Deng KM; Yao JH; Zhu L; Chen CY; Zhang M; Zhou JE; Shen TX; Chen HZ; Lu Y
Bioorg Med Chem Lett; 2007 Apr; 17(8):2260-6. PubMed ID: 17289384
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.
Jin J; Wang Y; Shi D; Wang F; Fu W; Davis RS; Jin Q; Foley JJ; Sarau HM; Morrow DM; Moore ML; Rivero RA; Palovich M; Salmon M; Belmonte KE; Busch-Petersen J
Bioorg Med Chem Lett; 2008 Oct; 18(20):5481-6. PubMed ID: 18818072
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics.
Minarini A; Marucci G; Bellucci C; Giorgi G; Tumiatti V; Bolognesi ML; Matera R; Rosini M; Melchiorre C
Bioorg Med Chem; 2008 Aug; 16(15):7311-20. PubMed ID: 18595721
[TBL] [Abstract][Full Text] [Related]
18. Nocardimicins A, B, C, D, E, and F, siderophores with muscarinic M3 receptor inhibiting activity from Nocardia sp. TP-A0674.
Ikeda Y; Nonaka H; Furumai T; Onaka H; Igarashi Y
J Nat Prod; 2005 Jul; 68(7):1061-5. PubMed ID: 16038549
[TBL] [Abstract][Full Text] [Related]
19. Nocardimicins G, H and I, siderophores with muscarinic M3 receptor binding inhibitory activity from Nocardia nova JCM 6044.
Ikeda Y; Furumai T; Igarashi Y
J Antibiot (Tokyo); 2005 Sep; 58(9):566-72. PubMed ID: 16320761
[TBL] [Abstract][Full Text] [Related]
20. M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.
Budzik B; Wang Y; Shi D; Wang F; Xie H; Wan Z; Zhu C; Foley JJ; Nuthulaganti P; Kallal LA; Sarau HM; Morrow DM; Moore ML; Rivero RA; Palovich M; Salmon M; Belmonte KE; Laine DI; Jin J
Bioorg Med Chem Lett; 2009 Mar; 19(6):1686-90. PubMed ID: 19243945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
